https://grxbiosims.org/
Generic + Biosimilar Medicines Conference
Jun 25, 2026 - GRx+Biosims is the premier U.S. event for generics and biosimilars, featuring regulatory insights, policy updates, and expert-led education.
biosimilar medicinesgenericconference
https://main-site-about-cancer.vercel.app/about-cancer/treatment/cancer-drugs/biosimilars
Biosimilar medicines | Treatment for cancer | Cancer Research UK
Your doctor may suggest you have a drug called a biosimilar. A biosimilar is a highly similar copy of an existing biological drug. Find out more.
biosimilar medicinestreatment forcancer researchuk
https://pr.euractiv.com/?q=pr/generic-biosimilar-medicines-pivotal-safe-effective-and-affordable-access-medicines-europe-197608
Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in...
The European Commission has identified the use of generic and biosimilar medicines as crucial for EU health systems in a report released today. Detailing the...
biosimilar medicines
https://biosimilarsresources.org/
Home | Biosimilars | Patient Resource Center | Biosimilar Medicines
Sep 13, 2024 - Biosimilar medicines give 1.2 million patients in the United States access to life-changing results. Learn more about these medicines.
patient resource centerbiosimilarsmedicines
https://www.medicinesuk.com/
Generic & Biosimilar Manufacturers Association | Medicines UK
Medicines UK is the trading name of the British Generic Manufacturers Association, which represents the suppliers of 85% of NHS prescription medicines,...
genericbiosimilarmanufacturersassociationmedicines
https://pr.euractiv.com/?q=pr/eu-pharma-strategy-success-depends-access-generic-biosimilar-and-value-added-medicines-209914
EU pharma strategy success depends on access to generic, biosimilar and value added medicines |...
The new EU pharmaceutical strategy must prioritise workable policies for generic, biosimilar and value added medicines to deliver on patient access to...
https://pr.euractiv.com/pr/igba-launches-whitepaper-vision-global-generic-and-biosimilar-medicines-industry-219548
IGBA LAUNCHES A WHITEPAPER: A VISION FOR THE GLOBAL GENERIC AND BIOSIMILAR MEDICINES INDUSTRY |...
Today the International Generic and Biosimilar Medicines Association (IGBA) is launching a whitepaper: A Vision for the Global Generic and Biosimilar Medicines...